Ansa Biotechnologies, Inc.

It was great to attend and sponsor an event that celebrates and supports the next generation of synthetic biology innovators! We're looking forward to the next one! Thanks, J. Craig Venter Institute and Tae Seok Moon for making it happen! #SynBYSS #synbio #syntheticbiology

𝗧𝗢𝗗𝗔𝗬! Mammalian synthetic biology is tricky, often requiring complex cloning strategies that can be difficult without modern DNA synthesis techniques. The Gao Lab at Stanford have had to overcome these challenges in the development of the innovative Retained Endoplasmic Cleavable Secretion (𝗥𝗘𝗟𝗘𝗔𝗦𝗘) platform, which allows protein secretion systems to achieve the same tuning capabilities seen in gene circuits but focused solely on proteins. It’s a great example of what enzymatic DNA synthesis can enable researchers to do, and we’re excited to highlight it in our next webinar. 🗓️ Tuesday, Dec. 10, 12pm ET 🔗 Sign up to watch live, or to get the recording: https://lnkd.in/egZEGwWH #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA #customDNA #AnsamerAnswers

A platform that allows protein secretion systems to achieve the same tuning capabilities seen in gene circuits? The Gao Lab has created just the thing, and it's made possible with enzymatic DNA synthesis by Ansa. Connor Clayton Call of the Gao Lab at Stanford University will join Ansa co-founder and CSO Daniel Lin-Arlow to discuss the innovative Retained Endoplasmic Cleavable Secretion (#RELEASE) platform and its potential applications in re-wiring and regulating intercellular communication, with implications for cancer biology, immunology, and neuroscience. They will also talk about the ins and outs of complex cloning strategies and the complexities involved with minimal sequence designs and repetitive motifs, which can be difficult without the modern DNA synthesis techniques that Ansa offers. 🗓️ Register for the free Dec 10 webinar to learn more: https://lnkd.in/egZEGwWH #DNAsynthesis #longDNA #Ansamers #biotech #synbio #SyntheticDNA #DNAInnovation #complexDNA  #customDNA #AnsamerAnswers

We’re excited to welcome Ansa Biotechnologies, Inc. as a Bronze Level Sponsor for the International SynBYSS Conference! Join us at University of Hawai’i at Manoa from December 9-12, 2024. Don’t miss your chance to be part of this transformative experience-register today! https://lnkd.in/eiQbZMZU

Our CTO, Sebastian Palluk, shares the journey from making 10mers to Ansa's new leap forward to 5 kb constructs.

At Ansa, we’re on a mission to end the headaches of ordering synthetic DNA and give researchers what they really want: reliable DNA, on time, exactly as ordered. With the exciting launch of our 5 kb clonal product today, our co-founder and Director of DNA Assembly, Jared Ellefson, shares how this will impact the scientific community. Read the blog: https://lnkd.in/ghMVuaEC

We are excited to announce the availability of our 5 kb clonal product! We excel at reliably delivering a wider range of sequences than other vendors. Our secret sauce comes from our ability to directly synthesize contiguous DNA molecules longer than 600 bases that we use to build your 5 kb constructs. Read the press release https://lnkd.in/gDqqn4y4 to learn more about our newest offering or register for an account https://lnkd.in/gbPaqW3X to request a quote and explore how Ansa can work with you on your dream project. #DNA #syntheticDNA

With tremendous gratitude, we acknowledge all of those individuals who have dedicated their lives in service to our country. Thank you to everyone who is serving or has served. 🇺🇸

"We’re not just optimizing the old way of doing things — we’re redefining what’s possible in DNA synthesis." Our CEO, Jason T. Gammack addresses the historic limitations of other DNA synthesis vendors and highlights how Ansa has built a fundamentally better system. #DNA ➡ Read: https://lnkd.in/gJEUVhw7

Everyone trips a little on their road to success, and we’re no different. In this second installment of our new video series, our cofounders share some amusing look-backs.